Evelo Biosciences Inc. (EVLO)
0.00
null (null%)
At close: Jan 14, 2025, 8:00 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Income | -108.47M | -115.40M | -91.89M | -86.36M | -58.10M | -27.53M | -13.03M |
| Interest Income | 4.67K | 3.61K | n/a | 1.05K | n/a | n/a | n/a |
| Pretax Income | -113.60M | -121.75M | -93.26M | -85.47M | -56.95M | -28.05M | -13.33M |
| Net Income | -114.53M | -122.18M | -93.67M | -85.66M | -53.85M | -28.05M | -13.33M |
| Selling & General & Admin | 29.91M | 31.75M | 22.27M | 23.23M | 18.22M | 7.57M | 3.89M |
| Research & Development | 78.55M | 83.64M | 69.62M | 63.13M | 39.88M | 19.96M | 9.13M |
| Other Expenses | n/a | 486.00K | -1.37M | 1.07M | 1.16M | -301.00K | -20.00K |
| Operating Expenses | 108.47M | 115.40M | 91.89M | 86.36M | 58.10M | 27.53M | 13.03M |
| Interest Expense | 4.67M | 3.61M | 2.11M | 1.05M | 1.56M | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 108.47M | 115.40M | 91.89M | 86.36M | 58.10M | 27.53M | 13.03M |
| Income Tax | 930.00K | 428.00K | 409.00K | 190.00K | -3.09M | 215.00K | 287.00K |
| Shares Outstanding (Basic) | 4.36M | 2.65M | 1.97M | 1.60M | 1.09M | 187.00K | 141.00K |
| Shares Outstanding (Diluted) | 4.36M | 2.65M | 1.97M | 1.60M | 1.09M | 187.54K | 141.74K |
| EPS (Basic) | -26.28 | -46.18 | -47.45 | -53.49 | -49.25 | -149.98 | -94.55 |
| EPS (Diluted) | -26.28 | -46.18 | -47.45 | -53.49 | -49.25 | -149.55 | -94.06 |
| EBITDA | -106.34M | -115.40M | -91.89M | -86.36M | -58.10M | -26.70M | -12.53M |
| Depreciation & Amortization | 2.06M | 2.22M | 2.03M | 1.76K | 1.94K | 834.00 | 495.00 |